General Regulation
NICE has opened a consultation on the possible mass rollout of tirzepatide to millions of people in England over the next decade.
PDA chair Mark Koziol has encouraged pharmacists to contribute to a doctor group’s legal war chest as they challenge their regulator on scope creep from MAPs.
The new government is “not in a position” to implement promised intercompany hub-and-spoke changes in January, the pharmacy negotiator has announced.
The time taken by the General Pharmaceutical Council (GPhC) to resolve FtP cases “deteriorated” in 2023/24, the Professional Standards Authority (PSA) has found in its performance review of the regulator.
Some seven pharmacists have been removed from the Northern Irish pharmacy register at once, it has revealed.
Northern Ireland’s pharmacy regulator has been “unable” to hire a new chief executive, it has revealed.
“Not following” the pharmacy regulator’s proposed new guidance on weight loss drugs and online pharmacy prescribing could result in fitness-to-practise (FtP) investigations into “all the pharmacy professionals involved”, it has warned.
Amardip Virdi bought the “entire stock” of Ozempic at a pharmacy where he was working during a national shortage to supply it to private weight loss customers, the GPhC’s investigating committee has found.
The Court of Appeal has reinstated mammoth fines imposed against manufacturers that had been set aside on procedural grounds earlier this year.
Changes to original pack dispensing from the start of 2025 mean pharmacists in England will be able to supply medication different from the prescribed quantity within a 10% margin. Here’s how the sector reacted…